Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Serotonin transporter polymorphism and fluoxetine effect on impulsiveness and aggression in borderline personality disorder.

Silva H, Iturra P, Solari A, Villarroel J, Jerez S, Vielma W, Montes C, Pumarino L, Roa N.

Actas Esp Psiquiatr. 2007 Nov-Dec;35(6):387-92.

PMID:
17597424
2.

Impulsive aggression in borderline personality disorder.

Goodman M, New A.

Curr Psychiatry Rep. 2000 Feb;2(1):56-61. Review.

PMID:
11122933
3.

Influence of SERTPR and STin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: a systematic review.

Smits KM, Smits LJ, Schouten JS, Stelma FF, Nelemans P, Prins MH.

Mol Psychiatry. 2004 May;9(5):433-41. Review.

PMID:
15037864
4.
5.

Psychopharmacology of borderline personality disorder.

Raj YP.

Curr Psychiatry Rep. 2004 Jun;6(3):225-31. Review.

PMID:
15142476
6.

Understanding the molecular pharmacology of the serotonergic system: using fluoxetine as a model.

Sghendo L, Mifsud J.

J Pharm Pharmacol. 2012 Mar;64(3):317-25. doi: 10.1111/j.2042-7158.2011.01384.x. Epub 2011 Nov 18. Review.

PMID:
22309263
7.

Psychopharmacological treatment in borderline personality disorder.

Díaz-Marsá M, González Bardanca S, Tajima K, García-Albea J, Navas M, Carrasco JL.

Actas Esp Psiquiatr. 2008 Jan-Feb;36(1):39-49. Review.

8.

Impulsivity.

Hollander E, Rosen J.

J Psychopharmacol. 2000;14(2 Suppl 1):S39-44. Review.

PMID:
10888030
9.

Is there any drug treatment of choice for the borderline patient?

Soloff PH.

Acta Psychiatr Scand Suppl. 1994;379:50-5. Review.

PMID:
8010152
10.
11.

[Heredity and role of serotonin in aggressive impulsive behavior].

Staner L, Mendlewicz J.

Encephale. 1998 Jul-Aug;24(4):355-64. Review. French.

PMID:
9809241
12.

Neurotransmitter dysfunction in patients with borderline personality disorder.

Gurvits IG, Koenigsberg HW, Siever LJ.

Psychiatr Clin North Am. 2000 Mar;23(1):27-40, vi. Review.

PMID:
10729929
13.

Recent trends in the pharmacotherapy of personality disorders.

Markovitz PJ.

J Pers Disord. 2004 Feb;18(1):90-101. Review.

PMID:
15061346
15.

The genetics of selective serotonin reuptake inhibitors.

Kroeze Y, Zhou H, Homberg JR.

Pharmacol Ther. 2012 Dec;136(3):375-400. doi: 10.1016/j.pharmthera.2012.08.015. Epub 2012 Sep 1. Review.

PMID:
22944042
16.

Medications in the treatment of borderline personality disorder 2006.

Mercer D.

Curr Psychiatry Rep. 2007 Feb;9(1):53-62. Review.

PMID:
17257515
17.

Dimensional classification and behavioral pharmacology of personality disorders; a review and hypothesis.

Tuinier S, Verhoeven WM.

Eur Neuropsychopharmacol. 1995 Jun;5(2):135-46. Review.

PMID:
7549456
18.

Fluoxetine pharmacogenetics in child and adult populations.

Blazquez A, Mas S, Plana MT, Lafuente A, Lázaro L.

Eur Child Adolesc Psychiatry. 2012 Nov;21(11):599-610. doi: 10.1007/s00787-012-0305-6. Epub 2012 Jul 12. Review.

PMID:
22791347
19.

The influence of fluoxetine on aggressive behavior.

Fuller RW.

Neuropsychopharmacology. 1996 Feb;14(2):77-81. Review.

20.

Safety and side effect profile of fluoxetine.

Wernicke JF.

Expert Opin Drug Saf. 2004 Sep;3(5):495-504. Review.

PMID:
15335304
Items per page

Supplemental Content

Write to the Help Desk